J Hebebrand

发表

Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder

S Cichon, S. Cichon, C. Freitag, 2012, Molecular Psychiatry.

Low leptin levels predict amenorrhea in underweight and eating disordered females

H Remschmidt, J. Hebebrand, H. Remschmidt, 1997, Molecular Psychiatry.

Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder

K Konrad, A Dempfle, H Remschmidt, 2005, Molecular Psychiatry.

No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation

H Remschmidt, J. Hebebrand, H. Remschmidt, 2007, The Pharmacogenomics Journal.

Association between an agouti-related protein gene polymorphism and anorexia nervosa

H Remschmidt, H. Engeland, R. Adan, 2001, Molecular Psychiatry.

[Percentiles of body mass index of 18-80-year-old German adults based on data from the Second National Nutrition Survey].

J. Hebebrand, C. Hemmelmann, M. Vens, 2010, Deutsche medizinische Wochenschrift.

Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa

G Heldmaier, H Remschmidt, J. Hebebrand, 2000, Molecular Psychiatry.

A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs

K Konrad, A Dempfle, H Remschmidt, 2006, Molecular Psychiatry.

Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration

H Remschmidt, J. Hebebrand, H. Remschmidt, 1997, Molecular Psychiatry.

The 5-HT2A −1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres

H Remschmidt, D. Collier, M. Gratacós, 2001, Molecular Psychiatry.